Steven J. McClue

<i>In vitro</i> and <i>in vivo</i> antitumor properties of the cyclin dependent kinase inhibitor CYC202 (R‐roscovitine)

Steven J. McClue, David Blake, Rosemary G. Clarke et al. · International Journal of Cancer · 2002 · 363 citations · Full text

<i>In vitro</i> and <i>In vivo</i> Pharmacokinetic-Pharmacodynamic Relationships for the Trisubstituted Aminopurine Cyclin-Dependent Kinase Inhibitors Olomoucine, Bohemine and CYC202

Florence I. Raynaud, Steven R. Whittaker, Peter M. Fischer et al. · Clinical Cancer Research · 2005 · 129 citations · Full text

Subacute and Chronic In Vivo Lithium Treatment Inhibits Agonist‐ and Sodium Fluoride‐Stimulated Inositol Phosphate Production in Rat Cortex

P P Godfrey, Steven J. McClue, Alison M. White et al. · Journal of Neurochemistry · 1989 · 109 citations

Discovery of a Novel Family of CDK Inhibitors with the Program LIDAEUS

S. Y. Wu, I.W. McNae, George Kontopidis et al. · Structure · 2003 · 105 citations · Full text

Cdk Inhibitors, Medicinal Chemistry, Medicine +12

Discovery and Characterization of 2-Anilino-4- (Thiazol-5-yl)Pyrimidine Transcriptional CDK Inhibitors as Anticancer Agents

Shudong Wang, Gary Griffiths, Carol Midgley et al. · Chemistry & Biology · 2010 · 101 citations · Full text

Medicinal Chemistry, Biochemistry, Medicine +7